tiprankstipranks
Trending News
More News >
Shandong Weigao Group Medical Polymer Co Ltd Class H (SHWGF)
OTHER OTC:SHWGF
US Market

Shandong Weigao Group Medical Polymer Co (SHWGF) Financial Statements

Compare
14 Followers

Shandong Weigao Group Medical Polymer Co Financial Overview

Shandong Weigao Group Medical Polymer Co's market cap is currently $3.55B. The company's EPS TTM is $0.063; its P/E ratio is 12.34; and it has a dividend yield of 4.46%. Shandong Weigao Group Medical Polymer Co is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 13.09B¥ 13.23B¥ 13.62B¥ 13.15B¥ 11.35B
Gross Profit¥ 6.58B¥ 6.64B¥ 7.11B¥ 7.27B¥ 6.46B
Operating Income¥ 2.39B¥ 2.18B¥ 3.56B¥ 3.32B¥ 2.61B
EBITDA¥ 3.14B¥ 3.55B¥ 4.38B¥ 3.75B¥ 3.30B
Net Income¥ 2.07B¥ 2.00B¥ 2.76B¥ 2.28B¥ 2.09B
Balance Sheet
Cash & Short-Term Investments¥ 8.32B¥ 7.33B¥ 7.36B¥ 7.06B¥ 5.98B
Total Assets¥ 34.76B¥ 33.67B¥ 33.20B¥ 30.37B¥ 27.34B
Total Debt¥ 4.19B¥ 4.17B¥ 4.49B¥ 4.14B¥ 4.32B
Net Debt¥ -3.59B¥ -2.82B¥ -2.37B¥ -2.49B¥ -1.19B
Total Liabilities¥ 9.42B¥ 9.68B¥ 9.75B¥ 9.46B¥ 8.95B
Stockholders' Equity¥ 23.75B¥ 22.45B¥ 21.67B¥ 19.27B¥ 17.55B
Cash Flow
Free Cash Flow¥ 2.14B¥ 2.11B¥ 1.10B¥ 1.92B¥ 1.70B
Operating Cash Flow¥ 2.79B¥ 2.80B¥ 2.21B¥ 3.04B¥ 2.70B
Investing Cash Flow¥ -1.10B¥ -1.39B¥ -2.57B¥ -1.48B¥ 423.22M
Financing Cash Flow¥ -1.60B¥ -2.16B¥ -1.02B¥ -538.08M¥ -1.79B
Currency in CNY

Shandong Weigao Group Medical Polymer Co Earnings and Revenue History

Shandong Weigao Group Medical Polymer Co Debt to Assets

Shandong Weigao Group Medical Polymer Co Cash Flow

Shandong Weigao Group Medical Polymer Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis